无创方法检测COVID-19机械通气患者高呼吸努力与跨肺驱动压
本研究纳入13例COVID-19机械通气患者,通过食管测压获得动态跨肺驱动压(△PL)和呼吸肌压(Pmus)作为金标准,同时用呼气末屏气 maneuver 获得的咬合压(△Pocc)计算△PL和Pmus。结果显示实测与计算值一致性低,但△Pocc可准确识别△PL>20 cmH2O(AUROC 1.00,敏感性100%,特异性100%)和Pmus>15 cmH2O(AUROC 0.98,敏感性100%,特异性86%)。每分钟呼吸努力指标与△Pocc高度相关(PTPes/min r2=0.73,P=0.0002;WOB r2=0.85,P<0.0001)。作者认为△PL和Pmus可由呼气末屏气 maneuver 计算,并能高精度预测COVID-19患者中过高的△PL和Pmus。
要点
- COVID-19机械通气患者中,呼气末屏气测△Pocc可高精度识别△PL>20 cmH2O(AUROC 1.00,敏感性100%,特异性100%)。
- △Pocc识别Pmus>15 cmH2O的AUROC为0.98,敏感性100%,特异性86%。
- 实测与计算的△PL、Pmus一致性低,不能直接互换数值。
- 每分钟呼吸努力与△Pocc高度相关:PTPes/min r2=0.73(P=0.0002),WOB r2=0.85(P<0.0001)。
适用人群与场景
- COVID-19机械通气患者,保留自主呼吸努力,纳入13例。
诊断标准与关键阈值
- 过高动态跨肺驱动压定义为△PL>20 cmH2O。
- 过高呼吸肌压定义为Pmus>15 cmH2O。
处置流程与药物剂量
- 通过呼气末屏气 maneuver 获得咬合压(△Pocc),并由此计算△PL和Pmus。
研究设计与关键结果
- 研究类型为诊断准确性研究,纳入13例COVID-19机械通气患者,动态肺顺应性低[24(20-31)mL/cmH2O],△PL高(25±6 cmH2O),Pmus高(16±7 cmH2O)。
- 实测与计算的△PL、Pmus一致性低。
- △Pocc识别△PL>20 cmH2O:AUROC 1.00(95%CI 1.00-1.00),敏感性100%(95%CI 72-100%),特异性100%(95%CI 16-100%)。
- △Pocc识别Pmus>15 cmH2O:AUROC 0.98(95%CI 0.90-1.00),敏感性100%(95%CI 54-100%),特异性86%(95%CI 42-100%)。
- 每分钟呼吸努力与△Pocc相关:PTPes/min r2=0.73(P=0.0002),WOB r2=0.85(P<0.0001)。
证据类型、等级与局限
- 证据类型:诊断准确性研究。
- 局限:样本量小(13例),实测与计算值一致性低,特异性置信区间宽。
对床旁实践的改变
- 作者认为,△PL和Pmus可由呼气末屏气 maneuver 计算,并能高精度预测COVID-19患者中过高的△PL和Pmus。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: High respiratory drive in mechanically ventilated patients with spontaneous breathing effort may cause excessive lung stress and strain and muscle loading. Therefore, it is important to have a reliable estimate of respiratory effort to guarantee lung and diaphragm protective mechanical ventilation. Recently, a novel non-invasive method was found to detect excessive dynamic transpulmonary driving pressure (∆PL) and respiratory muscle pressure (Pmus) with reasonable accuracy. During the Coronavirus disease 2019 (COVID-19) pandemic, it was impossible to obtain the gold standard for respiratory effort, esophageal manometry, in every patient. Therefore, we investigated whether this novel non-invasive method could also be applied in COVID-19 patients.
METHODS: ∆PL and Pmus were derived from esophageal manometry in COVID-19 patients. In addition, ∆PL and Pmus were computed from the occlusion pressure (∆Pocc) obtained during an expiratory occlusion maneuver. Measured and computed ∆PL and Pmus were compared and discriminative performance for excessive ∆PL and Pmus was assessed. The relation between occlusion pressure and respiratory effort was also assessed.
RESULTS: Thirteen patients were included. Patients had a low dynamic lung compliance [24 (20-31) mL/cmH2O], high ∆PL (25 ± 6 cmH2O) and high Pmus (16 ± 7 cmH2O). Low agreement was found between measured and computed ∆PL and Pmus. Excessive ∆PL > 20 cmH2O and Pmus > 15 cmH2O were accurately detected (area under the receiver operating curve (AUROC) 1.00 [95% confidence interval (CI), 1.00-1.00], sensitivity 100% (95% CI, 72-100%) and specificity 100% (95% CI, 16-100%) and AUROC 0.98 (95% CI, 0.90-1.00), sensitivity 100% (95% CI, 54-100%) and specificity 86% (95% CI, 42-100%), respectively). Respiratory effort calculated per minute was highly correlated with ∆Pocc (for esophageal pressure time product per minute (PTPes/min) r2 = 0.73; P = 0.0002 and work of breathing (WOB) r2 = 0.85; P < 0.0001).
CONCLUSIONS: ∆PL and Pmus can be computed from an expiratory occlusion maneuver and can predict excessive ∆PL and Pmus in patients with COVID-19 with high accuracy.
参考来源
- Roesthuis L, van den Berg M, van der Hoeven H, et al. Non-invasive method to detect high respiratory effort and transpulmonary driving pressures in COVID-19 patients during mechanical ventilation. Ann Intensive Care. 2021. PMID: 33555520. doi:10.1186/s13613-021-00821-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。